Fresenius | FRE - Net Income


Fresenius reported EUR361M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Akzo Nobel EUR 93M 505M Mar/2026
Alcon AG USD 189M 28M Mar/2026
AstraZeneca USD 3.08B 754M Mar/2026
BASF EUR 927M 367M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Beiersdorf EUR 387M 165M Dec/2025
DaVita Healthcare Partners USD 197.53M 36.69M Mar/2026
Demant DKK 427M 690M Dec/2025
E.ON EUR 2.23B 1.41B Mar/2026
Essilor EUR 928M 459M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
Getinge SEK 662M 661M Dec/2024
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GN Store Nord DKK -955M 1.3B Mar/2026
GRIFOLS EUR 73M 25.25M Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Philips EUR 151M 244M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
RWE EUR 20M 811M Mar/2026
Sanofi EUR 1.61B 2.42B Mar/2026
Smith & Nephew USD 293M 79M Dec/2025